| CXSB1300016 | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2013-09-22 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2015-05-04 | view |
| X0304086 | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(7) | New Drug Application | 2004-03-17 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2004-06-23 | view |
| CXSB1300017 | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2013-09-22 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2015-05-04 | view |
| X0400429 | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(7) | New Drug Application | 2004-02-04 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2004-08-30 | view |
| CXSL0500003 | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(7) | New Drug Application | 2005-02-22 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2005-11-23 | view |
| CXSB1400017 | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2014-12-26 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2016-10-11 | view |
| CYSB0900259 | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2009-10-10 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2010-04-01 | view |
| CYSB2300099 | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(原7) | Supplementary Application | 2023-05-22 | | Hisun Biopharmaceutical Co Ltd | | | view |
| CXSL0500045 | 注射用重组人II型肿瘤坏死因子受体－抗体融合蛋白 | | Lyophilized | Biological Products(7) | New Drug Application | 2005-06-19 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2006-12-30 | view |
| CXSS0700068 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(7) | New Drug Application | 2007-12-07 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2011-04-14 | view |
| CYSB1300123 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2013-06-03 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2014-01-03 | view |
| X0303849 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(14) | New Drug Application | 2003-08-06 | 上海中信国健药业有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2004-04-02 | view |
| CYSB1900326 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2019-09-19 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2019-12-13 | view |
| CXSS0500152 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(7) | New Drug Application | 2005-12-07 | 上海中信国健药业有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2012-07-27 | view |
| CXSS1000009 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(7) | New Drug Application | 2010-10-12 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2012-05-28 | view |
| CXSS0600036 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(7) | New Drug Application | 2006-03-13 | 上海中信国健药业有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2007-05-21 | view |
| CXSL1200038 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(15) | New Drug Application | 2012-08-16 | 苏州金盟生物技术有限公司 | Suzhou Genemen Biotech Co Ltd | Certificate Issued | 2015-01-15 | view |
| CXSS1900024 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(15) | New Drug Application | 2019-05-21 | 齐鲁制药有限公司 | QILU Pharmaceutical Co Ltd | In Review | 2019-05-20 | view |
| CYSB0900203 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2010-01-07 | 上海中信国健药业有限公司 | Sunshine Guojian Pharmaceutical(Shanghai) Co Ltd | Certificate Issued | 2011-04-12 | view |
| CXSL1100067 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(15) | New Drug Application | 2012-03-07 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | Certificate Issued | 2014-11-21 | view |
